$12M sweet spot round size
Most of their 12 investments are in rounds between $3M and $25M
1941
Casma Therapeutics raised $46M on November 15, 2022
Investors: Eventide Management Partners, Schroders Capital, Astellas Venture Capital L.L.C., The Column Group, Mirae Asset MAPS Global Investments Co., Ltd, Third Rock Ventures and Eisai Asia
ライフネット生命保険(株) raised $2.2M on August 9, 2022
Investors: Eisai Asia
中美瑞康医药科技(南通)有限公司 raised $30M on January 27, 2022
Investors: 襄禾商务咨询(北京)有限公司 and Eisai Asia
Neuroglee Therapeutics raised $10M on September 9, 2021
Investors: Openspace Ventures, EDBI Pte Ltd and Eisai Asia
Allm Inc. raised $50M on April 5, 2021
Investors: SBI Investment, Vector Holdings, Sompo Holdings (Asia), Cyberdyne and Eisai Asia
Neuroglee Therapeutics raised $2.3M on December 3, 2020
Investors: Eisai Asia
Unlearn.AI raised $3M on November 5, 2020
Investors: Alumni Ventures Group and Eisai Asia
Darmiyan raised $6.4M on April 10, 2020
Investors: Y Combinator, - and Eisai Asia
Numab Therapeutics AG raised $22M on December 12, 2019
Investors: Eisai Asia
Allm Inc. raised undisclosed on May 9, 2019
Investors: Eisai Asia